The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

1.2 - Comparisons drug-eluting stents

Sirolimus-eluting vs Everolimus-eluting stents for STEMI: BIOSTEMI


to investigate the safety and clinical efficacy of ultra thin strut biodegradable polymer SES compared to thin strut durable-polymer EES in patients with STEMI


multicentre, prospective, single blind randomised trial


patients with STEMI referred for primary PCI


target lesion failure as cardiac death, target vessel MI, clinical indicated TL revascularisation during 12 month follow-up




biodegradable polymer SES treatment was superior to durable polymer EES treatment in patients with STEMI

Iglesias et al. Lancet. 2019;394:1243-53

View next trial

Biodegradable polymer SES in STEMI: MASTER study

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from